World Cup resale ticket prices have fallen over the last month and have reached their lowest point since mid-January, according to numbers provided by TicketData. The average get-in price for a ...

If there's one idea that 18 years on this job has reinforced in me, it's that people by and large can't see beyond what's happening right now. They'll show the utmost discipline on Draft Day and then ...

We're a month into the baseball season, and fantasy managers are starting to lose patience with their slow starters. We need results, and we need them now. But hold your horses, some slow starters don ...

A nationwide recall of eye drops sold at major retailers like CVS, Walgreens and Kroger has expanded to include more than 3.1 million bottles over concerns the products may not be sterile. The ...

A California-based pharmaceutical company has expanded its national eye drops recall to include more than 3 million bottles distributed to retailers, including Walgreens, CVS and Rite Aid. K.C.

Add Yahoo as a preferred source to see more of our stories on Google. A nationwide recall of eye drops sold at major retailers like CVS, Walgreens and Kroger has expanded to include more than 3.1 ...

Hackers hijacked the npm account of the Axios package, a JavaScript HTTP client with 100M+ weekly downloads, to deliver remote access trojans to Linux, Windows, and macOS systems. One malicious ...

Dozens of refineries, oil fields, gas plants, ports and other energy infrastructure have been damaged by missile and drone strikes, six weeks since the war began. Senior US and Iranian officials are ...

In less than five months, Microsoft stock has fallen by nearly a third, even as the tech giant has continued to deliver strong results. The Windows-maker has gotten swept up in broader concerns about ...

AMC, the world’s largest movie theater chain and a one-time darling of meme stock traders, said this week that it expects to continue closing more movie theaters than it opens going forward. While the ...

Amid efforts on several fronts to improve the affordability of its GLP-1 medications for diabetes and obesity, Novo Nordisk is taking a new approach by aiming straight for semaglutide’s list price.